CRBP
Corbus Pharmaceuticals Holdings, Inc. · Healthcare · Market cap $152.3M
Insiders sold $283K net in the last 90 days ·3 sellers, 1 buyer· 3 of 3 sales under Rule 10b5-1 plans· latest Form 4 filed Sep 15, 2026
Insider Buying
$126K
reported purchases (SEC code P)
Insider Selling
$1.7M
reported sales (SEC code S)
Unique Insiders
10
in the rolling window
Latest filing
Sep 15, 2026
Ben Yong
Corbus Pharmaceuticals Holdings, Inc. (CRBP) has 30 SEC Form 4 filings (36 transaction rows) in the rolling window, disclosed by 10 distinct insiders. Most recent filing: Sep 15, 2026.
Inside the rolling window, 10 insiders at Corbus Pharmaceuticals Holdings, Inc. reported 3 open-market purchases totaling $126K and 17 open-market sales totaling $1.7M. The most active filer is Chief Executive Officer Cohen Yuval with 4 filings. Insiders have net sold $255K over the trailing 6 months. The most recent open-market filing is a sale of 2,000 shares by Director Ben Yong, dated Sep 14, 2026, worth $16K.
- Industry:Biotechnology
- CEO:Yuval Cohen
- Employees:36
- HQ:Norwood, MA, US
- IPO:2014-10-27
| Source | |||||||
|---|---|---|---|---|---|---|---|
Ben YongFirst filing | Director | Sale | 2,000 | $16K | Sep 15 | +13.8% | SEC ↗ |
| Chief Business Officer | Purchase | 2,600 | $25K | Aug 12 | -19.3% | SEC ↗ | |
Cohen YuvalFirst in 6 months | Chief Executive Officer | Sale | 17,000 | $171K | Aug 10 | -16.8% | SEC ↗ |
Moran Sean F.First in 6 months | Chief Financial Officer | Sale | 12,000 | $121K | Aug 10 | -16.8% | SEC ↗ |
Kung WinstonFirst filing | Director | Sale | 2,026 | $16K | Jun 11 | +1.2% | SEC ↗ |
Altmeyer AnneFirst in 8 months | Director | Sale | 2,412 | $19K | Jun 11 | +1.2% | SEC ↗ |
Jenkins John KennethFirst filing | Director | Sale | 4,800 | $38K | Jun 11 | +1.2% | SEC ↗ |
Saxena Nishant CFirst filing | Chief Business Officer | Purchase | 4,500 | $33K | Jun 3 | +6.7% | SEC ↗ |
Saxena Nishant CFirst filing | Chief Business Officer | Purchase | 9,000 | $68K | Jun 3 | +6.7% | SEC ↗ |
| Chief Medical Officer | Sale | 6,097 | $51K | Mar 4 | -6.5% | SEC ↗ | |
Moran Sean F.First in 4 months | Chief Financial Officer | Sale | 4,701 | $37K | Feb 18 | — | SEC ↗ |
Cohen YuvalFirst in 4 months | Chief Executive Officer | Sale | 13,871 | $108K | Feb 18 | — | SEC ↗ |
| Chief Operating Officer | Sale | 847 | $6K | Feb 18 | — | SEC ↗ | |
Smethurst DominicFirst filing | Chief Medical Officer | Sale | 3,285 | $27K | Feb 4 | — | SEC ↗ |
Hodgson IanFirst filing | Chief Operating Officer | Sale | 2,415 | $20K | Feb 4 | — | SEC ↗ |
| 10% Owner | Sale | 30,029 | $344K | Dec 15 | — | SEC ↗ | |
Cohen YuvalFirst filing | Chief Executive Officer | Sale | 18,660 | $317K | Oct 27 | — | SEC ↗ |
Cohen YuvalFirst filing | Chief Executive Officer | Sale | 8,973 | $154K | Oct 27 | — | SEC ↗ |
Moran Sean F.First filing | Chief Financial Officer | Sale | 12,981 | $221K | Oct 27 | — | SEC ↗ |
Altmeyer AnneFirst filing | Director | Sale | 1,060 | $22K | Oct 21 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does CRBP have?
Corbus Pharmaceuticals Holdings, Inc. (CRBP) has 30 SEC Form 4 filings (36 transaction rows) in the rolling 365-day window, disclosed by 10 distinct insiders. Most recent filing: Sep 15, 2026.
When was the most recent SEC Form 4 filing for CRBP?
The most recent Form 4 filing for CRBP on Tracefour is dated Sep 15, 2026.
Who is the most active insider at CRBP?
The most active SEC Form 4 filer at CRBP in the rolling window is Chief Executive Officer Cohen Yuval, with 4 filings.
What is the net insider flow at CRBP over the last 6 months?
Over the trailing 180 days, insiders at CRBP have net sold $255K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at CRBP in the current window?
Inside the rolling window, insiders at CRBP bought $126K and sold $1.7M based on SEC Form 4 filings.
Can I get alerts for CRBP insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Corbus Pharmaceuticals Holdings, Inc. (CRBP). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Corbus Pharmaceuticals Holdings, Inc. is in the Healthcare sector.